BG Medicine, Inc. (BGMD) Posts Narrower than Expected Q2 Loss
Tweet
Share
E-mailGet Alerts BGMD Hot Sheet
Join SI Premium – FREE
BG Medicine, Inc. (NASDAQ: BGMD) reported Q2 loss of ($0.25), $0.05 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $221 thousand versus the consensus estimate of $170 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Pan American Silver (PAAS) Misses Q2 EPS by 19c
- ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
